Neuroscientists illuminate role of autism-linked gene
- Details
- Written by Anne Trafton
- Category: Health News
Cambridge, Massachusetts - A new study from MIT neuroscientists reveals that a gene mutation associated with autism plays a critical role in the formation and maturation of synapses - the connections that allow neurons to communicate with each other.
AMA Statement on VA Proposed Rule on Advanced Practice Nurses
- Details
- Written by Kelly Jakubek
- Category: Health News
Washington, DC - Stephen R. Permut, MD, JD Board Chair, American Medical Association:
FDA approves Zinbryta to treat multiple sclerosis
- Details
- Written by IVN
- Category: Health News
The U.S. Food and Drug Administration Friday approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.
Antibiotic-resistant Superbug in U.S
- Details
- Written by Deborah Balzer
- Category: Health News
Rochester, Minnesota - The gene that makes bacteria highly resistant to a last-resort class of antibiotics is in the U.S. A report published in Antimicrobial Agents and Chemotherapy says the colistin-resistant mcr-1 E. coli has been discovered in a woman in Pennsylvania. Colistin, introduced in the 1950s, is used to treat multidrug resistant bacterial infections known as carbapenem-resistant Enterobacteriaceae (CRE).
New NIH-EPA research centers to study environmental health disparities
- Details
- Written by IVN
- Category: Health News
Washington, DC - The National Institutes of Health has partnered with the U.S. Environmental Protection Agency (EPA) to fund five new research centers to improve health in communities overburdened by pollution and other environmental factors that contribute to health disparities. Within each center, scientists will partner with community organizations to study these concerns and develop culturally appropriate ways to reduce exposure to harmful environmental conditions.
Surrogate Endpoints Poor Proxy for Survival in Cancer Drug Approval Process
- Details
- Written by Joe Dangor
- Category: Health News
Rochester, Minnesota - Surrogate endpoints used to support the majority of new cancer drugs approved in the U.S. often lack formal study, according to the authors of a study published in the June issue of Mayo Clinic Proceedings. This analysis questions whether the U.S. Food and Drug Administration (FDA) is adhering to standards that demand that surrogates be “reasonably likely to predict” or “established” to be used to grant approvals.
Page 3009 of 3785